919.783.4848
mstrahl@wyrick.com
Bio
Maddy is a corporate attorney in the firm’s Emerging Companies & Venture Capital group. Her practice focuses on advising high-growth businesses and investors in the areas of company formation, venture capital and other financings, strategic transactions, and corporate governance. Maddy primarily works with clients in the life sciences industry.
Maddy received her B.S. in Civil Engineering, summa cum laude, from the University of Notre Dame. Prior to attending law school, she worked as a structural engineer for the United States Army Corps of Engineers. She received her J.D., magna cum laude and Order of the Coif, and L.L.M. in Law and Entrepreneurship from Duke Law School, where she was a Mordecai Scholar.
- Listed among North Carolina Super Lawyers: Rising Stars (2026)
- Served as investor counsel in $10 million Series B investment in an immuno-oncology company.
- Represented local biotechnology startup in $3 million Series Seed Preferred Stock financing.
- Served as investor counsel in $7 million convertible debt investment in an immunotherapy company.
- Represented artificial-intelligence-driven software company in $50 million Series C Preferred Stock financing.
- Represented local drug development startup in $3M convertible debt financing.
- Represented global pharmaceutical company in multiple equity and convertible debt investments in US, UK, Canadian, Belgian, Australian and Danish portfolio companies.
- Served as outside general counsel to early-stage companies in formation and financing matters.
Recent posts from our emerging companies blog, Wyrick Ventures.
